{"id":"W2300207219","doi":"10.1634/theoncologist.2016-0069","title":"Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?","year":2016,"lang":"en","type":"letter","venue":"The Oncologist","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Cardiotoxicity; Dexrazoxane; Trastuzumab; Anthracycline; Cardioprotection; Oncology; Doxorubicin; Regimen; Internal medicine; Pharmacology; Adverse effect; Clinical trial; Cardiology; Chemotherapy; Cancer; Myocardial infarction; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005285171,0.0008775573,0.002037137,0.0006548782,0.0006249978,0.002837098,0.002223229,0.004655684,0.004105649],"category_scores_gemma":[0.01390966,0.0002954843,0.001100783,0.0004705884,0.002397235,0.0062569,0.0008322389,0.007648671,0.001477702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001188693,"about_ca_system_score_gemma":0.001648219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002044846,"about_ca_topic_score_gemma":0.00401334,"domain_scores_codex":[0.9981446,0.0007790659,0.0001936179,0.0002649526,0.0004508684,0.0001669551],"domain_scores_gemma":[0.9904531,0.006100238,0.0005484612,0.0003737845,0.001588832,0.0009355259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009894976,0.0008721334,0.008770453,0.004211795,0.0002743808,0.006521931,0.0005995526,0.000654619,0.002369538,0.005405148,0.06104508,0.9082858],"study_design_scores_gemma":[0.0008777347,0.008376837,0.04102394,0.03530891,0.001531843,0.06209214,0.007989701,0.006568167,0.005277182,0.05936711,0.7708583,0.000728092],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.02228917,0.7023406,0.005164207,0.2509269,0.0100911,0.0001469241,0.0001931629,0.0002732479,0.008574716],"genre_scores_gemma":[0.1397503,0.6463314,0.01629837,0.1470536,0.04625497,0.0001986167,0.0003850059,0.0001070609,0.003620797],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.005285171,"threshold_uncertainty_score":0.027951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06247023935942844,"score_gpt":0.3184028482091724,"score_spread":0.255932608849744,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}